Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alzchem Group AGCHIX:ACTD 59 Revenue per Share is €57.19 as of Jun. 2026. GuruFocus rates CHIX:ACTD with a GF Score™ of 59/100 and a GF Value™ of €68.61 (Significantly Overvalued). Among 1,529 Chemicals companies, Alzchem Group AG ranks better than 56.25% on this metric.
Alzchem Group AG's revenue per share for the
three
months ended in Jun. 2026 was €15.34.
Alzchem Group AG's revenue per share for the trailing twelve months (TTM) ended in Jun. 2026 was €57.19.
During the past 12 months, the average Revenue Per Share Growth Rate of Alzchem Group AG was 4.40% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 1.30% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 8.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Alzchem Group AG's Revenue per Share or its related term are showing as below:
CHIX:ACTd'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 1.3 Med: 6.75 Max: 13.1
Current: 1.3
During the past 13 years, Alzchem Group AG's highest 3-Year average Revenue Per Share Growth Rate was 13.10% per year. The lowest was 1.30% per year. And the median was 6.75% per year.
CHIX:ACTd's 3-Year Revenue Growth Rate is ranked better than 56.25% of 1529
companies
in the Chemicals industry
Industry Median: -0.4
vs CHIX:ACTd: 1.30
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Alzchem Group AG Revenue per Share Related Terms
Alzchem Group AG Revenue per Share Historical Data
* Premium members only.
The historical data trend for Alzchem Group AG's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:ACTD vs LIN, SHW, ECL: Revenue per Share Comparison
For the Specialty Chemicals subindustry, Alzchem Group AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alzchem Group AG PS Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Alzchem Group AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where Alzchem Group AG's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Alzchem Group AG's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €57.19
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alzchem Group AG (CHIX:ACTD) has a Revenue per Share of €57.19 as of Jun. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Alzchem Group AG and its competitors. According to the industry distribution chart, Alzchem Group AG ranks #669 out of 1529 companies in the Chemicals industry, placing it in the top 43.8%.
Is Alzchem Group AG's Revenue per Share too high?
Alzchem Group AG's current Revenue per Share is €57.19. Based on the distribution chart, Alzchem Group AG ranks #669 out of 1529 companies in the Chemicals industry, which is above the industry midpoint. Overall, Alzchem Group AG has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alzchem Group AG's Revenue per Share compare to LIN and SHW?
According to the Chemicals industry distribution chart, Alzchem Group AG ranks #669 out of 1529 companies for Revenue per Share. This puts Alzchem Group AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Chemicals company?
A good Revenue per Share depends on the Chemicals industry context. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Alzchem Group AG and its competitors. Alzchem Group AG's current Revenue per Share is €57.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzchem Group AG stock overvalued right now?
Based on GuruFocus' analysis, Alzchem Group AG (CHIX:ACTD) is currently considered Significantly Overvalued. The stock's GF Value™ is €68.61, compared to a current price of €177.05 — trading 158.1% above its estimated fair value. The current Revenue per Share is €57.19. Alzchem Group AG's overall GF Score™ is 59/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Alzchem Group AG (CHIX:ACTD), the current Revenue per Share is €57.19 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alzchem Group AG (CHIX:ACTD) Overvalued in 2026?
Based on GuruFocus' analysis, Alzchem Group AG stock appears to be overvalued.
The current stock price of €177.05 is trading 158.1% above its estimated GF Value™ of €68.61.
GuruFocus considers Alzchem Group AG to be Significantly Overvalued.
Key valuation signals for CHIX:ACTD:
Revenue per Share: €57.19
GF Value™: €68.61 vs. price of €177.05 (158.1% above fair value)
No single metric tells the full story. See the CHIX:ACTD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alzchem Group AG is an international chemical company. The reportable segments of the company are Specialty Chemicals, Basics and Intermediates, and Other Holdings. The specialty chemicals segment focuses on the production and distribution of high-quality growth products, and the basics and intermediates segment covers the production of basic and intermediate products. It generates a majority of its revenue from the Specialty Chemical segment. Geographically it serves Europe, Asia, and the Rest of the world whilst deriving substantial revenue from European Union.
59GF Score
Get the complete analysis for CHIX:ACTD
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ACTD has been successfully added to your 
